Stock Analysis on Net
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 

Biogen Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Current portion of notes payable 4.18 0.00 5.49 0.00 0.01
Taxes payable 0.73 0.58 0.26 0.25 0.29
Accounts payable 2.47 1.85 1.95 1.47 1.67
Revenue-related reserves for discounts and allowances 3.36 4.39 3.68 3.46 2.42
Collaboration expenses 1.36 1.58 1.03 1.03 0.78
Employee compensation and benefits 1.45 1.36 1.13 1.27 1.26
Royalties and licensing fees 0.98 0.89 0.81 0.89 0.87
Derivative liabilities 0.05 0.74 0.02 0.00 0.00
Current portion of contingent consideration obligations 0.00 0.61 0.54 1.76 3.57
Other 3.43 3.21 2.93 2.90 3.37
Accrued expense and other 10.62% 12.78% 10.16% 11.31% 12.27%
Current liabilities 18.00% 15.20% 17.86% 13.03% 14.24%
Notes payable, excluding current portion 26.28 30.16 16.37 23.47 25.09
Deferred tax liability 2.91 4.20 10.32 6.47 0.52
Long-term operating lease liabilities 1.38 1.63 1.52 0.00 0.00
Other long-term liabilities 5.53 5.40 4.95 5.49 6.89
Long-term liabilities 36.10% 41.39% 33.16% 35.44% 32.50%
Total liabilities 54.10% 56.59% 51.02% 48.47% 46.74%
Preferred stock, par value $0.001 per share 0.00 0.00 0.00 0.00 0.00
Common stock, par value $0.0005 per share 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 0.29 0.00 0.00 0.00 0.41
Accumulated other comprehensive loss -0.45 -1.21 -0.50 -0.95 -1.35
Retained earnings 58.26 56.77 60.42 64.29 66.84
Treasury stock, at cost -12.47 -12.09 -10.93 -11.77 -12.59
Total Biogen Inc. shareholders’ equity 45.63% 43.46% 48.99% 51.56% 53.33%
Noncontrolling interests 0.27 -0.06 -0.02 -0.03 -0.06
Total equity 45.90% 43.41% 48.98% 51.53% 53.26%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Biogen Inc. current liabilities as a percentage of total liabilities and equity decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Biogen Inc. long-term liabilities as a percentage of total liabilities and equity increased from 2019 to 2020 but then slightly decreased from 2020 to 2021 not reaching 2019 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Biogen Inc. total liabilities as a percentage of total liabilities and equity increased from 2019 to 2020 but then slightly decreased from 2020 to 2021.
Total Biogen Inc. shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Biogen Inc. total Biogen Inc. shareholders’ equity as a percentage of total liabilities and equity decreased from 2019 to 2020 but then slightly increased from 2020 to 2021.